Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[Assessment of a set of FRAX(®)-based criteria for the indication of bone densitometry in Spanish postmenopausal women].

Gómez-Vaquero C, Roig-Vilaseca D, Bianchi M, Santo P, Narváez J, Nolla JM.

Med Clin (Barc). 2013 May 13;140(10):439-43. doi: 10.1016/j.medcli.2012.03.008. Epub 2012 May 9. Spanish.

PMID:
22578993
2.

The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX.

Gómez-Vaquero C, Bianchi M, Santo P, Roig-Vilaseca D, Narváez J, Nolla JM.

Reumatol Clin. 2012 Jul-Aug;8(4):179-83. doi: 10.1016/j.reuma.2012.02.003. Epub 2012 May 18.

3.

[FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].

Azagra R, Roca G, Martín-Sánchez JC, Casado E, Encabo G, Zwart M, Aguyé A, Díez-Pérez A; en representación del grupo de investigación GROIMAP..

Med Clin (Barc). 2015 Jan 6;144(1):1-8. doi: 10.1016/j.medcli.2013.11.014. Epub 2014 Jan 24. Spanish.

PMID:
24461732
4.

Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey.

Olmez Sarikaya N, Kapar Yavasi S, Tan G, Satiroglu S, Yildiz AH, Oz B, Yoleri O, Memis A.

Clin Rheumatol. 2014 Dec;33(12):1785-9. doi: 10.1007/s10067-014-2491-8. Epub 2014 Jan 29.

PMID:
24474067
5.

Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.

Bastos-Silva Y, Aguiar LB, Pinto-Neto AM, Baccaro LF, Costa-Paiva L.

Arch Osteoporos. 2016;11:16. doi: 10.1007/s11657-015-0255-y. Epub 2016 Apr 11.

PMID:
27067597
6.

Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.

Ahmed LA, Shigdel R, Joakimsen RM, Eldevik OP, Eriksen EF, Ghasem-Zadeh A, Bala Y, Zebaze R, Seeman E, Bjørnerem Å.

Osteoporos Int. 2015 Aug;26(8):2137-46. doi: 10.1007/s00198-015-3118-x. Epub 2015 Apr 16.

7.

[Comparison fracture risk calculated by FRAX tool].

Carranza-Lira S, Lanuza-López MC, Sandoval-Barragán MP.

Ginecol Obstet Mex. 2014 Sep;82(9):591-4. Spanish.

PMID:
25412552
8.

[Prevalence of osteopenia and osteoporosis assessed by densitometry in postmenopausal women].

Guzmán Ibarra M, Ablanedo Aguirre J, Armijo Delgadillo R, García Ruíz Esparza M.

Ginecol Obstet Mex. 2003 May;71:225-32. Spanish.

PMID:
12908337
9.

Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.

Baró F, Cano A, Sánchez Borrego R, Ferrer J, González Rodríguez SP, Neyro JL, Rodriguez Bueno E, Sancho C, Inaraja V, Fernández C, Corral C; FROSPE Study Group..

Menopause. 2012 Nov;19(11):1193-9. doi: 10.1097/gme.0b013e31825d65c5.

PMID:
22948137
10.

Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.

Arch Intern Med. 2004 May 24;164(10):1108-12.

PMID:
15159268
11.
12.

Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.

Chao AS, Chen FP, Lin YC, Huang TS, Fan CM, Yu YW.

Taiwan J Obstet Gynecol. 2015 Dec;54(6):722-5. doi: 10.1016/j.tjog.2015.10.005.

13.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
14.

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM.

JAMA. 2001 Dec 12;286(22):2815-22.

PMID:
11735756
16.

Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.

Cheung E, Cheung CL, Kung AW, Tan KC.

Osteoporos Int. 2014 Mar;25(3):1017-23. doi: 10.1007/s00198-013-2553-9. Epub 2013 Nov 6.

PMID:
24196720
17.

Association of breast vascular calcifications with low bone mass in postmenopausal women.

Nasser EJ, Iglésias ER, Ferreira JA, Fernandes CE, Pompei LM.

Climacteric. 2014 Aug;17(4):486-91. doi: 10.3109/13697137.2013.869672. Epub 2014 Feb 4.

PMID:
24286614
18.

Relationship between body composition, body mass index and bone mineral density in a large population of normal, osteopenic and osteoporotic women.

Andreoli A, Bazzocchi A, Celi M, Lauro D, Sorge R, Tarantino U, Guglielmi G.

Radiol Med. 2011 Oct;116(7):1115-23. doi: 10.1007/s11547-011-0689-2. Epub 2011 Jun 4. English, Italian.

PMID:
21643640
19.

Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study.

Roux C, Fardellone P, Lespessailles E, Cotté FE, Mercier F, Gaudin AF.

Joint Bone Spine. 2008 Dec;75(6):702-7. doi: 10.1016/j.jbspin.2007.12.007. Epub 2008 Jul 9.

PMID:
18617431
20.

Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit.

Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM.

J Rheumatol. 2007 Jun;34(6):1307-12.

PMID:
17552058

Supplemental Content

Support Center